New England Journal of Medicine publishes COVID-19 treatment trial results
January 27, 2021
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health found that a combination of the drugs baricitinib and remdesivir reduced time to recovery.
